Gerald W. Bruce - 25 Apr 2022 Form 4 Insider Report for Virpax Pharmaceuticals, Inc. (VRPX)

Role
Director
Signature
/s/ Christopher Chipman, attorney-in-fact
Issuer symbol
VRPX
Transactions as of
25 Apr 2022
Net transactions value
$0
Form type
4
Filing time
27 Apr 2022, 18:00:21 UTC
Previous filing
05 Aug 2021
Next filing
26 Apr 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VRPX Stock Option (right to buy) Award $0 +60,000 $0.000000 60,000 25 Apr 2022 Common Stock 60,000 $1.76 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.